Loraz and Cinvanti drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Cinvanti (aprepitant). Common drug interactions include neutropenic colitis among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Cinvanti. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Cinvanti?

Cinvanti has active ingredients of aprepitant. eHealthMe is studying from 150 Cinvanti users. Check the latest studies of Cinvanti.

On Jul, 09, 2026

11 people who take Loraz and Cinvanti together, and have interactions are studied.

What are the common drug interactions of Loraz and Cinvanti, by gender? *:

female:

Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
Dizziness
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Infusion related reaction

male:

Abdominal pain
Alanine aminotransferase increased
Gait disturbance
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pneumonia
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Urinary tract infection
Weight decreased

What are the common drug interactions of Loraz and Cinvanti, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dysgeusia (disorder of the sense of taste)
Vomiting

30-39:

Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Infusion related reaction

40-49:

n/a

50-59:

n/a

60+:

Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
Abdominal pain
Fatigue (feeling of tiredness)
Gait disturbance
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pneumonia
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Urinary tract infection

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Cinvanti?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously